US Edition
Palatin Technologies (PTN) Q3 Earnings Call: What Investors Need to Know
Summary by Trading Tips
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Palatin Technologies (PTN) Q3 Earnings Call: What Investors Need to Know
Palatin Technologies (PTN) recently held its Q3 earnings call, and there were some key takeaways for investors to note. The biopharmaceutical company reported a net loss of $4.2 million, or $0.03 per share, for the quarter, which was in line with analysts’ expectations. However, the company’s revenue of $1.7 million surpassed expectations, largely due to an upfront payment from its collaboration with AMAG Pharmaceuticals. One major highlight fro…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage